ClinVar Miner

Submissions for variant NM_000089.4(COL1A2):c.179G>A (p.Gly60Asp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV003388655 SCV004100346 uncertain significance Ehlers-Danlos syndrome, cardiac valvular type criteria provided, single submitter clinical testing The missense variant p.G60D in COL1A2 (NM_000089.4) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.G60D variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The gene COL1A2 contains 184 pathogenic missense variants, indicating that missense variants are a common mechanism of disease in this gene. The p.G60D missense variant is predicted to be damaging by both SIFT and PolyPhen2. The glycine residue at codon 60 of COL1A2 is conserved in all mammalian species. The nucleotide c.179 in COL1A2 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.